tiprankstipranks
Trending News
More News >
VitaSpring Biomedical (VSBC)
OTHER OTC:VSBC
US Market

VitaSpring Biomedical (VSBC) Income Statement

Compare
3 Followers

VitaSpring Biomedical Income Statement

Last quarter (Q3 2023), VitaSpring Biomedical's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, VitaSpring Biomedical's net income was $-138.00K. See VitaSpring Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jan 23Jan 22Jan 21Jan 20Jan 19
Total Revenue
$ 0.00$ 5.61M$ 248.20K$ 15.14K$ 17.18K
Gross Profit
$ -219.34K$ 2.07M$ 112.20K$ 1.70K$ 13.27K
Operating Expenses
$ 3.96M$ 584.53K$ 536.91K$ 21.18K$ 34.60K
Depreciation and Amortization
$ 219.34K$ 8.36K$ 450.00$ 450.00-
EBITDA
$ -3.95M$ 1.49M$ -424.26K$ -19.04K$ -21.95K
Operating Income
$ -4.18M$ 1.48M$ -425.38K$ -19.49K$ -21.33K
Other Income/Expenses
$ 8.06K$ -2.36K$ -670.00$ 0.00$ 0.00
Pretax Income
$ -4.17M$ 1.48M$ -425.38K$ 6.92K$ -22.40K
Net Income
$ -4.16M$ 1.26M$ -425.38K$ 6.92K$ -22.40K
Per Share Metrics
Basic EPS
$ -0.02$ <0.01$ 0.00$ <0.01$ >-0.01
Diluted EPS
$ -0.02$ <0.01$ 0.00$ <0.01$ >-0.01
Weighted Average Shares Outstanding
206.52M 205.98M 91.09M 54.51M 25.15M
Weighted Average Shares Outstanding (Diluted)
206.52M 205.98M 91.09M 54.51M 25.15M
Currency in USD

VitaSpring Biomedical Earnings and Revenue History